Literature DB >> 25347269

The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.

Jessica Roessler1, Ole Ammerpohl, Jana Gutwein, Doris Steinemann, Brigitte Schlegelberger, Veronika Weyer, Murat Sariyar, Robert Geffers, Norbert Arnold, Rita Schmutzler, Claus R Bartram, Tilman Heinrich, Mahmoud Abbas, Wiebke Antonopoulos, Elisa Schipper, Britta Hasemeier, Hans Kreipe, Ulrich Lehmann.   

Abstract

BACKGROUND: Aberrations in DNA methylation patterns are well-described in human malignancies. However, the existence of the 'CpG island methylator phenotype' (CIMP) in human breast cancer is still controversial. MATERIALS &
METHODS: Illumina's HumanMethylation 450K BeadChip was used to analyze genome-wide DNA methylation patterns. Chromosomal abnormalities were determined by array-based CGH.
RESULTS: Invasive lobular breast carcinomas exhibit the highest number of differentially methylated CpG sites and a strong inverse correlation of aberrant DNA hypermethylation and copy number alterations. Nine differentially methylated regions within seven genes discriminating the investigated subgroups were identified and validated in an independent validation cohort and correlated to a better relapse-free survival.
CONCLUSION: These results depict a clear difference between genetically and epigenetically unstable breast carcinomas indicating different ways of tumor progression and/or initiation, which strongly supports the association of CIMP with the lobular subtype and provide new options for detection and therapy.

Entities:  

Keywords:  CpG island methylator phenotype; DNA methylation; breast cancer; epigenetics; lobular breast cancer

Mesh:

Year:  2014        PMID: 25347269     DOI: 10.2217/epi.14.74

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  16 in total

1.  Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.

Authors:  Ines Florath; Katja Butterbach; Jonathan Heiss; Melanie Bewerunge-Hudler; Yan Zhang; Ben Schöttker; Hermann Brenner
Journal:  Diabetologia       Date:  2015-10-03       Impact factor: 10.122

Review 2.  Breast cancer intrinsic subtype classification, clinical use and future trends.

Authors:  Xiaofeng Dai; Ting Li; Zhonghu Bai; Yankun Yang; Xiuxia Liu; Jinling Zhan; Bozhi Shi
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

Review 3.  Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.

Authors:  Diego M Marzese; Dave Sb Hoon
Journal:  Expert Rev Mol Diagn       Date:  2015-03-22       Impact factor: 5.225

Review 4.  Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.

Authors:  Stanley Zhou; Aislinn E Treloar; Mathieu Lupien
Journal:  Cancer Discov       Date:  2016-10-19       Impact factor: 39.397

5.  The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.

Authors:  Belén Pérez-Mies; Tamara Caniego-Casas; Irene Carretero-Barrio; Michele Biscuola; María A López-García; David Hardisson; Marta Rosas; María J López Rodríguez; Eva Cristóbal; David Pizarro; Juan M Rosa-Rosa; José Palacios
Journal:  Am J Surg Pathol       Date:  2022-07-25       Impact factor: 6.298

6.  O6-Methylguanine-DNA Methyltransferase and ATP-Binding Cassette Membrane Transporter G2 Promotor Methylation: Can Predict the Response to Chemotherapy in Advanced Breast Cancer?

Authors:  Sara Ahmed Aglan; Ahmad Mohamad Zaki; Amel Sobhy El Sedfy; Heba Gaber El-Sheredy; Ola Hussein Elgaddar
Journal:  Rep Biochem Mol Biol       Date:  2022-04

7.  Acute lymphoblastic leukemia displays a distinct highly methylated genome.

Authors:  Sara Hetzel; Alexandra L Mattei; Helene Kretzmer; Chunxu Qu; Xiang Chen; Yiping Fan; Gang Wu; Kathryn G Roberts; Selina Luger; Mark Litzow; Jacob Rowe; Elisabeth Paietta; Wendy Stock; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan; Alexander Meissner
Journal:  Nat Cancer       Date:  2022-05-19

8.  Methylated biomarkers for breast cancer identified through public database analysis and plasma target capture sequencing.

Authors:  Can Luo; Jiaheng Huang; Zhaoze Guo; Jingyun Guo; Xiaoqi Zeng; Yimin Li; Minfeng Liu
Journal:  Ann Transl Med       Date:  2021-04

9.  Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.

Authors:  Javed Hussain Choudhury; Sankar Kumar Ghosh
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

10.  DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.

Authors:  Halaleh Shakeri; Jalal Gharesouran; Ashraf Fakhrjou; Ali Esfahani; Seyyed Mojtaba Mohaddes Ardebili
Journal:  EXCLI J       Date:  2016-01-11       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.